Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer-Reference-Cited by-同舟云学术

Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer

Published:2017-09-23 Issue:11 Volume:11 Page:1544-1560
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Tian Xianglong¹,Zhu Xiaoqiang¹,Yan Tingting¹,Yu Chenyang¹,Shen Chaoqin¹,Hu Ye¹,Hong Jie¹,Chen Haoyan¹,Fang Jing-Yuan¹

Affiliation:

1. Division of Gastroenterology and Hepatology; Key Laboratory of Gastroenterology and Hepatology; Ministry of Health; State Key Laboratory for Oncogenes and Related Genes; Renji Hospital; School of Medicine; Shanghai Institute of Digestive Disease; Shanghai JiaoTong University; China

Funder

National Natural Science Foundation of China

Shanghai Municipal Education Commission

Shanghai Jiao Tong University

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference76 articles.

1. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis;Agesen;Gut,2012

2. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases;Andreou;Ann Surg,2012

3. Systematic review of genetic influences on the prognosis of colorectal cancer;Anwar;Br J Surg,2004